Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue for Neonatal Septic Shock
NCT06306001Phase 3Not yet recruiting
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Mar 2024
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylene blue in septic shock, neonatal sepsis, sponsored by Post Graduate Institute of Medical Education and Research. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
methylene blue
03
Conditions
septic shockneonatal sepsis
Beyond the preview
Go deeper on NCT06306001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06306001.